# Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window

Study · id `cardio:ct-nct06987305` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06987305](<https://clinicaltrials.gov/study/NCT06987305>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06987305

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.

## Technical summary

Registry record NCT06987305. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2027-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 820 participants (planned count; ClinicalTrials.gov record NCT06987305, source copy `cardio:ctgov-nct06987305-2025-12-31`, retrieved 2026-10-26)
- Started: 2025-10-21 (actual) (ClinicalTrials.gov record NCT06987305, source copy `cardio:ctgov-nct06987305-2025-12-31`, retrieved 2026-10-26)
- Primary completion: 2027-10-31 (anticipated) (ClinicalTrials.gov record NCT06987305, source copy `cardio:ctgov-nct06987305-2025-12-31`, retrieved 2026-10-26)
- Completion: 2028-02-29 (anticipated) (ClinicalTrials.gov record NCT06987305, source copy `cardio:ctgov-nct06987305-2025-12-31`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06987305, source copy `cardio:ctgov-nct06987305-2025-12-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06987305-2025-12-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
- Condition: Stroke, Acute Ischemic
- Intervention (Drug): Intravenous rhTNK-tPA
- Intervention (Drug): Intravenous placebo
- Intervention (Procedure): Endovascular thrombectomy
- Lead sponsor: Xinqiao Hospital of Chongqing
- Lead sponsor class: OTHER
- Collaborator: The First Affiliated Hospital of Nanchang University
- Collaborator class: OTHER
- Collaborator: China Shijiazhuang Pharmaceutical Company RECOMGEN PHARMACEUTICAL (GUANGZHOU) CO.,LTD
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xinqiao Hospital of Chongqing (`cardio:org-xinqiao-hospital-of-chongqing`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of Nanchang University (`cardio:org-the-first-affiliated-hospital-of-nanchang-university`)

## Provenance

Content hash: 7af972acd92721fe4360dcc24fc67aa548973023a4297ea716a9a34b2693971c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
